Ekso Bionics Holdings Inc (EKSO) - Net Assets
Based on the latest financial reports, Ekso Bionics Holdings Inc (EKSO) has net assets worth $9.03 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($20.11 Million) and total liabilities ($11.08 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read how much debt does Ekso Bionics Holdings Inc carry for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $9.03 Million |
| % of Total Assets | 44.89% |
| Annual Growth Rate | 106.87% |
| 5-Year Change | -75.75% |
| 10-Year Change | 38.22% |
| Growth Volatility | 38902.5 |
Ekso Bionics Holdings Inc - Net Assets Trend (2011–2025)
This chart illustrates how Ekso Bionics Holdings Inc's net assets have evolved over time, based on quarterly financial data. Also explore how large is Ekso Bionics Holdings Inc's balance sheet for the complete picture of this company's asset base.
Annual Net Assets for Ekso Bionics Holdings Inc (2011–2025)
The table below shows the annual net assets of Ekso Bionics Holdings Inc from 2011 to 2025. For live valuation and market cap data, see market value of Ekso Bionics Holdings Inc.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $9.03 Million | -28.96% |
| 2024-12-31 | $12.71 Million | +0.80% |
| 2023-12-31 | $12.61 Million | -50.45% |
| 2022-12-31 | $25.44 Million | -31.64% |
| 2021-12-31 | $37.22 Million | +739.40% |
| 2020-12-31 | $4.43 Million | -34.77% |
| 2019-12-31 | $6.80 Million | +149.16% |
| 2018-12-31 | $2.73 Million | -87.25% |
| 2017-12-31 | $21.39 Million | +227.53% |
| 2016-12-31 | $6.53 Million | -25.85% |
| 2015-12-31 | $8.81 Million | -61.37% |
| 2014-12-31 | $22.80 Million | +151384.95% |
| 2013-12-31 | $15.05K | 0.00% |
| 2012-12-31 | $15.05K | +4288.05% |
| 2011-12-31 | $343.00 | -- |
Equity Component Analysis
This analysis shows how different components contribute to Ekso Bionics Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 26239134300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $37.00K | 0.41% |
| Other Comprehensive Income | $-692.00K | -7.67% |
| Other Components | $272.08 Million | 3014.05% |
| Total Equity | $9.03 Million | 100.00% |
Ekso Bionics Holdings Inc Competitors by Market Cap
The table below lists competitors of Ekso Bionics Holdings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Dyadic International Inc
NASDAQ:DYAI
|
$28.59 Million |
|
Workhorse Group Inc
NASDAQ:WKHS
|
$28.60 Million |
|
DIAMINES AND CHEMICALS ORD (BSE)
NSE:DIAMINESQ
|
$28.60 Million |
|
GFM Services Bhd
KLSE:0039
|
$28.60 Million |
|
GLORY HEALTH IND. HD-001
F:84R
|
$28.58 Million |
|
Prestar Resources Bhd
KLSE:9873
|
$28.57 Million |
|
SFD SA ZY -10
F:7PQ
|
$28.55 Million |
|
Geekay Wires Limited
NSE:GEEKAYWIRE
|
$28.55 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ekso Bionics Holdings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 12,707,000 to 9,027,000, a change of -3,680,000 (-29.0%).
- Net loss of 11,695,000 reduced equity.
- Dividend payments of 226,000 reduced retained earnings.
- New share issuances of 4,098,000 increased equity.
- Other comprehensive income decreased equity by 1,649,000.
- Other factors increased equity by 5,792,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-11.70 Million | -129.56% |
| Dividends Paid | $226.00K | -2.5% |
| Share Issuances | $4.10 Million | +45.4% |
| Other Comprehensive Income | $-1.65 Million | -18.27% |
| Other Changes | $5.79 Million | +64.16% |
| Total Change | $- | -28.96% |
Book Value vs Market Value Analysis
This analysis compares Ekso Bionics Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.17x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 189.93x to 3.17x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | $0.06 | $11.79 | x |
| 2013-12-31 | $0.06 | $11.79 | x |
| 2014-12-31 | $23.61 | $11.79 | x |
| 2015-12-31 | $6.98 | $11.79 | x |
| 2016-12-31 | $5.26 | $11.79 | x |
| 2017-12-31 | $9.01 | $11.79 | x |
| 2018-12-31 | $0.67 | $11.79 | x |
| 2019-12-31 | $1.42 | $11.79 | x |
| 2020-12-31 | $0.62 | $11.79 | x |
| 2021-12-31 | $3.03 | $11.79 | x |
| 2022-12-31 | $1.96 | $11.79 | x |
| 2023-12-31 | $0.91 | $11.79 | x |
| 2024-12-31 | $0.63 | $11.79 | x |
| 2025-12-31 | $3.72 | $11.79 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ekso Bionics Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -129.56%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -91.37%
- • Asset Turnover: 0.64x
- • Equity Multiplier: 2.23x
- Recent ROE (-129.56%) is above the historical average (-7345.54%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -99940.20% | -555.88% | 92.75x | 1.94x | $-15.04 Million |
| 2013 | -81.67% | -0.37% | 113.18x | 1.94x | $-13.80K |
| 2014 | -148.11% | -633.92% | 0.16x | 1.47x | $-36.05 Million |
| 2015 | -222.41% | -226.19% | 0.27x | 3.66x | $-20.47 Million |
| 2016 | -359.36% | -165.04% | 0.58x | 3.74x | $-24.12 Million |
| 2017 | -136.14% | -396.06% | 0.19x | 1.78x | $-31.26 Million |
| 2018 | -989.44% | -238.19% | 0.64x | 6.47x | $-27.26 Million |
| 2019 | -178.49% | -87.17% | 0.64x | 3.22x | $-12.81 Million |
| 2020 | -356.90% | -178.17% | 0.43x | 4.65x | $-16.27 Million |
| 2021 | -26.23% | -86.82% | 0.23x | 1.32x | $-13.49 Million |
| 2022 | -59.27% | -116.79% | 0.32x | 1.61x | $-17.62 Million |
| 2023 | -120.56% | -83.14% | 0.63x | 2.29x | $-16.46 Million |
| 2024 | -89.16% | -63.21% | 0.67x | 2.10x | $-12.60 Million |
| 2025 | -129.56% | -91.37% | 0.64x | 2.23x | $-12.60 Million |
Industry Comparison
This section compares Ekso Bionics Holdings Inc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,863,507,886
- Average return on equity (ROE) among peers: -17.76%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ekso Bionics Holdings Inc (EKSO) | $9.03 Million | -99940.20% | 1.23x | $28.58 Million |
| Akoya Biosciences Inc (AKYA) | $121.35 Million | -35.38% | 0.57x | $64.44 Million |
| Align Technology Inc (ALGN) | $1.35 Billion | 32.89% | 0.86x | $12.66 Billion |
| AngioDynamics Inc (ANGO) | $517.03 Million | -1.36% | 0.37x | $444.32 Million |
| AptarGroup Inc (ATR) | $2.71 Billion | 14.48% | 0.94x | $7.66 Billion |
| AtriCure Inc (ATRC) | $16.74 Million | -22.66% | 1.01x | $1.44 Billion |
| Avinger Inc (AVGR) | $-73.64 Million | 0.00% | 0.00x | $1.52 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $10.52 Million | -163.15% | 1.04x | $156.14 Million |
| Avantor Inc (AVTR) | $5.57 Billion | -9.53% | 1.12x | $5.43 Billion |
| Azenta Inc (AZTA) | $553.69 Million | -12.55% | 0.24x | $1.04 Billion |
| Baxter International Inc (BAX) | $7.87 Billion | 19.65% | 1.00x | $8.85 Billion |
About Ekso Bionics Holdings Inc
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It … Read more